Problems With Drug Absorption Studies Still ‘Relatively Common’ In EU

Inadequacies Have Drawn Major Objections During Initial EMA Review

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".